A structural insight into the Chandipura virus (CHPV) proteins with an aim to repurpose commercially available antiviral drugs against them
- 8 September 2026
- journal article
- research article
- Published by Springer Nature in Proceedings of the Indian National Science Academy
- p. 1-25
Abstract
No abstract availableKeywords
This publication has 111 references indexed in Scilit:
- CHARMM-GUI ligand reader and modeler for CHARMM force field generation of small moleculesJournal of Computational Chemistry, 2017
- Using PyMOL as a platform for computational drug designWIREs Computational Molecular Science, 2017
- A comparative molecular dynamics study of thermophilic and mesophilic β-fructosidase enzymesJournal of Molecular Modeling, 2015
- Development of antiviral drugs for the treatment of hepatitis C at an accelerating paceReviews in Medical Virology, 2015
- Small-Molecule Library Screening by Docking with PyRx2014
- Telaprevir‐based treatment effects on hepatitis C virus in liver and bloodHepatology, 2014
- CHARMM‐GUI: A web‐based graphical user interface for CHARMMJournal of Computational Chemistry, 2008
- Structures of vesicular stomatitis virus glycoprotein: membrane fusion revisitedCellular and Molecular Life Sciences, 2008
- Antiviral effects of amantadine and iminosugar derivatives against hepatitis C virus†Hepatology, 2007
- Amantadine and rimantadine for preventing and treating influenza A in adults2002